SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of acquisition of beneficial ownership by individuals: [Amend]
SEC Accession No. 0001104659-19-006433
Filing Date
2019-02-08
Accepted
2019-02-08 06:02:11
Documents
1
Group Members
ATLAS VENTURE ASSOCIATES IX, L.P.ATLAS VENTURE ASSOCIATES IX, LLC

Document Format Files

Seq Description Document Type Size
1 SC 13G/A a19-4142_2sc13ga.htm SC 13G/A 146012
  Complete submission text file 0001104659-19-006433.txt   147622
Mailing Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139
Business Address 40 ERIE STREET SUITE 130 CAMBRIDGE MA 02139 857-285-6200
Intellia Therapeutics, Inc. (Subject) CIK: 0001652130 (see all company filings)

IRS No.: 364785571 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89486 | Film No.: 19577153
SIC: 2835 In Vitro & In Vivo Diagnostic Substances
Office of Life Sciences

Mailing Address 25 FIRST ST STE 303 CAMBRIDGE MA 02141
Business Address 25 FIRST ST STE 303 CAMBRIDGE MA 02141 6175882695
Atlas Venture Fund IX, L.P. (Filed by) CIK: 0001671219 (see all company filings)

IRS No.: 461357890 | State of Incorp.: DE | Fiscal Year End: 1012
Type: SC 13G/A